Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACP-001 vs Standard Daily rhGH in Prepubertal Children With Growth Hormone Deficiency
NCT01947907Phase 2Completed
- Sponsor
- Ascendis Pharma
- Start
- Jul 2013
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes, Prodrugs/Conditional Activator Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of ACP-001 in growth hormone deficiency (GHD), sponsored by Ascendis Pharma. Started Jul 2013; status: completed.
02
Drugs
ACP-001
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01947907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01947907.